Jefferies Group Reiterates “Buy” Rating for Consort Medical (CSRT)
Consort Medical (LON:CSRT)‘s stock had its “buy” rating restated by equities researchers at Jefferies Group in a research report issued on Monday, Stock Ratings Network reports. They currently have a GBX 1,000 ($16.43) price target on the stock. Jefferies Group’s target price points to a potential downside of 6.54% from the company’s current price.
Several other analysts have also recently commented on the stock. Analysts at FinnCap reiterated a “sell” rating on shares of Consort Medical in a research note to investors on Thursday, December 19th. They now have a GBX 690 ($11.34) price target on the stock. Separately, analysts at N+1 Singer raised their price target on shares of Consort Medical from GBX 870 ($14.30) to GBX 1,020 ($16.76) in a research note to investors on Tuesday, December 10th. They now have a “buy” rating on the stock. Finally, analysts at Numis Securities Ltd reiterated an “add” rating on shares of Consort Medical in a research note to investors on Wednesday, December 4th. They now have a GBX 940 ($15.45) price target on the stock. One analyst has rated the stock with a sell rating, four have assigned a hold rating and four have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of GBX 938.43 ($15.42).
Consort Medical (LON:CSRT) traded up 0.38% during mid-day trading on Monday, hitting GBX 1070.00. The stock had a trading volume of 436,370 shares. Consort Medical has a one year low of GBX 660.50 and a one year high of GBX 1113.00. The stock has a 50-day moving average of GBX 959.2 and a 200-day moving average of GBX 886.5. The company’s market cap is £307.8 million.
Consort Medical plc a healthcare company focused on medical technologies. The Company with its subsidiaries is engaged in the principal activities of design, development and manufacture of specialty medical drug delivery devices and services to the pharmaceutical industry through and disposable airway management products for critical care settings in hospitals and pre-hospital settings.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.